This content is from: Premium

Inside Sarissa’s Healthy Returns

Why the Tiger Cub and Icahn alum is outperforming other health-care funds.

It has been a rough year for many health-care-focused hedge funds, with a number of them either in the red or barely breaking even.Not Sarissa Capital Management’s funds, however.Its main long-short fund, Sarissa Capital, was up 18.1 percent in the first half of the year, while Sarissa Capital Domestic Fund

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content